Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Edwards Lifesciences Corp Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$81.41 - $94.33 $94,435 - $109,422	1,160 New	1,160 $109,000
Q3 2022 Oct 18, 2022	SELL	$82.37 - $107.29 $326,679 - $425,512	-3,966 Reduced 79.8%	1,004 $83,000
Q2 2022 Jul 19, 2022	BUY	$86.5 - $128.27 $120,148 - $178,167	1,389 Added 38.79%	4,970 $473,000
Q1 2022 Apr 13, 2022	BUY	$101.96 - $128.34 $365,118 - $459,585	3,581 New	3,581 $427,000
Q3 2021 Oct 13, 2021	SELL	$102.91 - $122.75 $1.77 Million - $2.12 Million	-17,242 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$83.84 - $104.76 $997,444 - $1.25 Million	-11,897 Reduced 40.83%	17,242 $1.79 Million
Q1 2021 Apr 20, 2021	BUY	$78.68 - $90.67 $1.4 Million - $1.62 Million	17,838 Added 157.84%	29,139 $2.44 Million
Q3 2020 Oct 20, 2020	SELL	$67.19 - $87.44 $254,381 - $331,047	-3,786 Reduced 25.09%	11,301 $902,000
Q2 2020 Jul 16, 2020	BUY	$57.54 - $76.95 $371,017 - $496,173	6,448 Added 74.64%	15,087 $1.04 Million
Q1 2020 Apr 23, 2020	SELL	$52.41 - $81.0 $208,486 - $322,218	-3,978 Reduced 31.53%	8,639 $1.63 Million
Q4 2019 Jan 17, 2020	SELL	$71.7 - $82.09 $462,249 - $529,234	-6,447 Reduced 33.82%	12,617 $2.93 Million
Q3 2019 Oct 29, 2019	BUY	$61.55 - $75.43 $384,810 - $471,588	6,252 Added 48.8%	19,064 $4.13 Million
Q2 2019 Jul 17, 2019	BUY	$55.74 - $64.41 $84,334 - $97,452	1,513 Added 13.39%	12,812 $2.38 Million
Q1 2019 Apr 29, 2019	BUY	$47.89 - $64.05 $359,127 - $480,310	7,499 Added 197.34%	11,299 $2.13 Million
Q4 2018 Jan 29, 2019	SELL	$46.41 - $56.94 $900,400 - $1.1 Million	-19,401 Reduced 83.62%	3,800 $572,000
Q3 2018 Oct 23, 2018	BUY	$45.7 - $58.03 $325,978 - $413,927	7,133 Added 44.39%	23,201 $3.97 Million
Q2 2018 Jul 17, 2018	SELL	$42.45 - $51.3 $904,439 - $1.09 Million	-21,306 Reduced 57.01%	16,068 $2.38 Million
Q1 2018 May 02, 2018	BUY	$37.19 - $47.45 $1.01 Million - $1.29 Million	27,261 Added 269.56%	37,374 $5.09 Million
Q4 2017 Jan 26, 2018	SELL	$33.79 - $39.39 $1.57 Million - $1.83 Million	-46,487 Reduced 82.13%	10,113 $1.17 Million
Q3 2017 Nov 06, 2017	BUY	$36.29 - $38.83 $2.05 Million - $2.2 Million	56,600	56,600 $6.18 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account